1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is €4.21 (+2,706.67%). The median is €4.21 (+2,706.67%).
| Buy |
4 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Mar 2026 | |
|---|---|---|
| Revenue | 41.9K | - |
| Gross profit | 41.9K | - |
| Net profit | -11.87M | 584.79% |
| EBITDA | -7.29M | 436.82% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €3.44M |
Number of shares | 23.53M |
52-week high/low | €11.91 - €0.12 |
| Dividends | No |
Beta | 0.61 |
P/E ratio | -0.02 |
PEG ratio | 0.00 |
P/B ratio | 0.38 |
P/S ratio | 41.05 |
Company profile
| Name | PORTAGE BIOTECH Aktie |
| CEO | Brittany Kaiser |
| Employees | 22 |
Discover assets
Shareholders of PORTAGE BIOTECH Aktie also invest in the following assets
